Your browser doesn't support javascript.
loading
In silico repurposing of midostaurin as a therapeutic candidate for head and neck cancer via targeting SPARC/MMP9/CD44 Cancer-Associated Fibroblasts (CAFs) oncogenic signature.
Lin, Kuan-Chou; Wu, Chia-Che; Mokgautsi, Ntlotlang; Lawal, Bashir; Wu, Ching-Zong; Wu, Alexander Th; Shen, Yung-Kang; Liu, Ming-Che.
Afiliación
  • Lin KC; Division of Oral and Maxillofacial Surgery, Department of Dentistry, Wan Fang Hospital, Taipei Medical University Taipei 11031, Taiwan.
  • Wu CC; Division of Oral and Maxillofacial Surgery, Department of Dentistry, Shin Kong Wu Ho-Su Memorial Hospital Taipei, Taiwan.
  • Mokgautsi N; School of Dentistry, College of Oral Medicine, Taipei Medical University Taipei 11031, Taiwan.
  • Lawal B; Taipei Medical University, School of Medicine, Department of Otorhinolaryngology Taipei 11031, Taiwan.
  • Wu CZ; Taipei Medical University, Wang Fang Hospital, Department of Otorhinolaryngology Taipei 11031, Taiwan.
  • Wu AT; Program for Cancer Molecular Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University and Academia Sinica Taipei 11031, Taiwan.
  • Shen YK; Graduate Institute of Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University Taipei 11031, Taiwan.
  • Liu MC; Department of Pathology, University of Pittsburgh Pittsburgh, PA 15232, USA.
Am J Cancer Res ; 13(3): 1004-1025, 2023.
Article en En | MEDLINE | ID: mdl-37034220
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Risk_factors_studies Idioma: En Revista: Am J Cancer Res Año: 2023 Tipo del documento: Article País de afiliación: Taiwán
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Risk_factors_studies Idioma: En Revista: Am J Cancer Res Año: 2023 Tipo del documento: Article País de afiliación: Taiwán